Enlivex Therapeutics Ltd. Quarterly Marketable Securities, Current in USD from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Enlivex Therapeutics Ltd. quarterly Marketable Securities, Current history and growth rate from Q2 2021 to Q2 2024.
  • Enlivex Therapeutics Ltd. Marketable Securities, Current for the quarter ending June 30, 2024 was $228K.
Marketable Securities, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $228K Jun 30, 2024 6-K 2024-08-30
Q4 2023 $5.11M Dec 31, 2023 6-K 2024-08-30
Q4 2021 $62.9M Dec 31, 2021 20-F 2023-04-10
Q2 2021 $68M Jun 30, 2021 6-K 2021-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.